z-logo
open-access-imgOpen Access
Gefitinib in Patients with Advanced Non-small-Cell Lung Cancer
Author(s) -
Magdalena KnetkiWróblewska,
Dariusz M. Kowalski,
Katarzyna Zajda,
Adam Płużański,
Paweł Badurak,
Anna Janowicz-Żebrowska,
Piotr Jaśkiewicz,
Maciej Krzakowski
Publication year - 2012
Publication title -
advances in respiratory medicine
Language(s) - English
Resource type - Journals
eISSN - 2543-6031
pISSN - 2451-4934
DOI - 10.5603/arm.27563
Subject(s) - gefitinib , medicine , tolerability , lung cancer , oncology , expanded access , epidermal growth factor receptor , adverse effect , common terminology criteria for adverse events , progression free survival , cancer , chemotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom